Company ELDN Nasdaq Irvine, CA Eledon Pharmaceuticals Eledon Pharmaceuticals, a clinical-stage company based in Irvine, California, develops tegoprubart, an anti-CD40L antibody, for kidney and liver transplantation, xenotransplantation, islet cell transplantation, and amyotrophic lateral sclerosis.
4 Stories, 2 about Eledon Pharmaceuticals 1 Program 2 Registered trials 424B4 Sep 28 Latest SEC filing Sep 23 Latest story
Timeline 2 Pipeline 1 Trials 2
Pipeline by stage
Phase 3 1
Details
Headquarters Irvine, CA Incorporated Delaware Industry Pharmaceutical Preparations Formerly Eledon Pharmaceuticals, Inc. (to 2026); Novus Therapeutics, Inc. (to 2020); Tokai Pharmaceuticals Inc (to 2017) Also known as ELDN, Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc How the company describes itself Eledon Pharmaceuticals, a clinical-stage company based in Irvine, California, develops tegoprubart, an anti-CD40L antibody, for kidney and liver transplantation, xenotransplantation, islet cell transplantation, and amyotrophic lateral sclerosis. source
